The tariff classification of Posaconazole Delayed-Release Tablets in dosage form, from India
Issued November 17, 2022 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3004.90.9209
Headings: 3004
Product description
Posaconazole, imported in 100 mg delayed-release tablets, is a triazole antifungal drug. It is used to treat invasive infections by Candida species and Aspergillus species in severely immunocompromised patients.
CBP rationale
The applicable subheading for Posaconazole Delayed-Release Tablets in dosage form will be 3004.90.9209, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Anti-infective medicaments: Antifungals.
Full text
N328957 November 17, 2022 CLA-2-30:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 3004.90.9209 Ms. Carol Glenny Avila NorthStar Healthcare 3300 Cork Airport Business Park Kinsale Road, Cork T12 XN72 Ireland RE: The tariff classification of Posaconazole Delayed-Release Tablets in dosage form, from India Dear Ms. Glenny Avila: In your letter dated October 25, 2022, you requested a tariff classification ruling. Posaconazole, imported in 100 mg delayed-release tablets, is a triazole antifungal drug. It is used to treat invasive infections by Candida species and Aspergillus species in severely immunocompromised patients. The applicable subheading for Posaconazole Delayed-Release Tablets in dosage form will be 3004.90.9209, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Anti-infective medicaments: Antifungals.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on the World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of clinical trial kits from the United States
The tariff classification of Voriconazole Tablets in dosage form, from India
The tariff classification of Fluconazole Tablets in dosage form, from India
The tariff classification of Ketoconazole Cream 2% in dosage form, from Canada
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →